TITLE

Long-term leave with training, mentoring keeps company talent pool well stocked

AUTHOR(S)
Carlson, Leah
PUB. DATE
January 2005
SOURCE
Employee Benefit News;1/1/2005, Vol. 19 Issue 1, p38
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Looks at the long-term leave program being implemented by New York City-based consulting firm Deloitte & Touche LLP and Indianapolis, Indiana-based pharmaceutical company Eli Lilly & Co. Reaction of Deloitte employees to the program; Impact of childbirth on the relationship between an employer and an employee; Details of the Personal Pursuits leave program for senior-level employees at Deloitte.
ACCESSION #
15620246

 

Related Articles

  • Lilly employees will land downtown, in 'burbs. Culbertson, Katie // Indianapolis Business Journal;07/26/99, Vol. 20 Issue 19, p6 

    Comments on the impact of pharmaceutical firm Eli Lilly and Co.'s planned addition of 7,500 employees to its Indianapolis, Indiana, operations through 2009. Implications for the downtown Indianapolis housing market; Effect on downtown business activity.

  • Lilly dusts off manufacturing site for training center. Murphy, Tom // Indianapolis Business Journal;1/26/2004, Vol. 24 Issue 47, p7 

    Reports on the plan of drugmaker Eli Lilly and Co. to convert the manufacturing site into a global training center in Indianapolis, Indiana. Removal of penicillin powder traces; Preparation of new employees; Maintenance of the needed documentation.

  • ‘Unfortunately strong [pipelines] can become weak quickly and vice versa. Sometimes things don't persist.’. Krensavage, Michael // Indianapolis Business Journal;11/1/2004, Vol. 25 Issue 34, p48 

    Reports on the strategy of drug manufacturer Eli Lilly & Co. to combat the declining sales of the company in the U.S. Reduction of unnecessary expenses by retrenching employees; Promotion of the drug Zyprexa; Elimination of research projects with small odds of success.

  • A silver lining to Lilly's cuts.  // Indianapolis Business Journal;4/21/2008, Vol. 29 Issue 7, p10 

    The article comments on the decision by drug firm Eli Lilly and Co. to cut 500 of its 12,800 local jobs through buyouts in Indianapolis, Indiana. The author admits the decision deals a blow to the local economy. However, the author believes the decision comes as the company faces an array of...

  • Lilly to double sales force.  // Medical Marketing & Media;Nov2001, Vol. 36 Issue 11, p25 

    Reports on the plan of Eli Lilly company to increase the number of sales executives in the U.S.

  • LILLY'S TERIPARATIDE GETS POSITIVE OPINION FROM CPMP.  // Worldwide Biotech;Feb2003, Vol. 15 Issue 2, p8 

    Reports on the positive opinion issued by the European Committee for Proprietary Medicinal Products concerning the teriparatide (rDNA origin) injection from Lilly.

  • Eli Lilly and Co.  // Indianapolis Business Journal;3/24/2003, Vol. 24 Issue 2, p35 

    Features Eli Lilly and Co., an Indianapolis, Indiana-based pharmaceutical company. Stock value; Major shareholders; Executive compensation; Corporate directors.

  • Lilly looms larger. Jefferson, Greg // Indianapolis Business Journal;07/19/99, Vol. 20 Issue 18, p1A 

    Reports on Indianapolis, Indiana-based drug firm Eli Lilly's expansion plan in Indiana. Company profile; Effect on the cultural and economic makeup of Indiana; Pledge of investments for construction and renovation projects; Projects; Addition of employees. INSET: In first speech to Indy...

  • Lilly banks on R&D. Jefferson, Greg // Indianapolis Business Journal;07/26/99, Vol. 20 Issue 19, p1 

    Reports on Eli Lilly and Co.'s plan to invest $1 billion into its pharmaceutical operations in Indianapolis, Indiana. Recruitment of researchers, computer specialists and technicians; Construction of new facilities.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics